Bolt Biotherapeutics (BOLT) Research & Development (2020 - 2025)
Historic Research & Development for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $6.5 million.
- Bolt Biotherapeutics' Research & Development fell 5259.34% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.3 million, marking a year-over-year decrease of 4318.1%. This contributed to the annual value of $57.5 million for FY2024, which is 661.82% down from last year.
- Bolt Biotherapeutics' Research & Development amounted to $6.5 million in Q3 2025, which was down 5259.34% from $7.5 million recorded in Q2 2025.
- Bolt Biotherapeutics' Research & Development's 5-year high stood at $22.5 million during Q4 2021, with a 5-year trough of $6.5 million in Q3 2025.
- Over the past 5 years, Bolt Biotherapeutics' median Research & Development value was $16.0 million (recorded in 2023), while the average stood at $15.4 million.
- In the last 5 years, Bolt Biotherapeutics' Research & Development skyrocketed by 11500.11% in 2021 and then crashed by 5259.34% in 2025.
- Bolt Biotherapeutics' Research & Development (Quarter) stood at $22.5 million in 2021, then fell by 25.08% to $16.8 million in 2022, then decreased by 3.1% to $16.3 million in 2023, then fell by 28.18% to $11.7 million in 2024, then tumbled by 44.25% to $6.5 million in 2025.
- Its last three reported values are $6.5 million in Q3 2025, $7.5 million for Q2 2025, and $9.5 million during Q1 2025.